News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Tesi Raymond Joseph
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Sold 3,626 shares
@ $20, valued at
$72.5k
|
|
10/29/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Sold 6,517 shares
@ $20, valued at
$130.3k
|
|
10/26/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Sold 23,616 shares
@ $20, valued at
$472.3k
|
|
08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/09/2021 |
4
| Tesi Raymond Joseph (President and CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Sold 5,649 shares
@ $20.018, valued at
$113.1k
Sold 24,351 shares
@ $20.08, valued at
$489k
|
|
06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/27/2019 |
4
| Tesi Raymond Joseph (President & CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Granted 300,000 options
@ $3.91, valued at
$1.2M
|
|
08/21/2019 |
4
| Tesi Raymond Joseph (President & CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Bought 100 shares
@ $5.96, valued at
$596 Bought 100 shares
@ $5.9239, valued at
$592.4 Bought 1,000 shares
@ $6.0308, valued at
$6k
|
|
08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2019 |
4
| Tesi Raymond Joseph (President & CEO) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Bought 10,000 shares
@ $6, valued at
$60k
|
|
05/06/2019 |
4
| Tesi Raymond Joseph (Chairman) has filed a Form 4 on Inmune Bio, Inc.
Txns:
| Bought 11,100 shares
@ $9.9, valued at
$109.9k
|
|
|
|